Pibrentasvir | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Pibrentasvir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 2 KDMF, 3 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 2 FDA Orange Book, 1 Europe, 2 Canada

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 SPI Pharma, 1 Seqens, 3 DKSH, 2 Jai Radhe Sales, 1 PMC Isochem, 2 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 2 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 1 Bioplus Life Sciences, 3 DFE Pharma, 2 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 1 Ingredion Pharma Solutions, 14 Kerry, 3 Microlex e.U, 1 NEWEDGE Overseas, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Sigachi Industries, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

31 Fillers, Diluents & Binders, 15 Direct Compression, 12 Disintegrants & Superdisintegrants, 9 Lubricants & Glidants, 8 Film Formers & Plasticizers, 8 Granulation, 7 Coating Systems & Additives, 5 Co-Processed Excipients, 4 Emulsifying Agents, 3 Thickeners and Stabilizers, 3 Solubilizers, 2 Coloring Agents, 2 Topical, 2 Controlled & Modified Release, 2 Chewable & Orodispersible Aids, 2 Parenteral, 2 Taste Masking, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 31 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 Finished Drug Prices, 5 Annual Reports

MARKET PLACE

4 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

40 US Patents, 8 US Exclusivities

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

5 All

01 5Mavyret

List of Suppliers

Product Main Page

01

Brand Name : Mavyret

2024 ACI Convention

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Pibrentasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,830

2019 Revenue in Millions : 2,893

Growth (%) : -37

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Mavyret

2024 ACI Convention

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Pibrentasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 1,710

2020 Revenue in Millions : 1,830

Growth (%) : -7

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Mavyret

2024 ACI Convention

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Pibrentasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 1,541

2021 Revenue in Millions : 1,710

Growth (%) : -10

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Mavyret

2024 ACI Convention

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Pibrentasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 1,430

2022 Revenue in Millions : 1,541

Growth (%) : -7

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Mavyret

2024 ACI Convention

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Pibrentasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 2,893

2018 Revenue in Millions : 3,438

Growth (%) : -16

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info